Clinical trial tooling Rapid focuses on multi-center trials for radiopharmaceuticals and offers protocol development and FDA-ready reporting, signaling demand for scalable data management, standardized workflows, and regulatory-compliant documentation services.

Cloud-enabled dosimetry Recent NIH grant and cloud-based quantitative SPECT reconstruction development indicate a growing need for cloud-native dosimetry solutions, offering an opportunity to position Rapid as a partner for scalable imaging analytics and platform integrations.

Regulatory readiness With activities around FDA-ready reports and protocol development, there is a sales opening for services that streamline regulatory submission support, audit trails, and compliance consulting for radiopharmaceutical trials.

Mid-market focus Company size (11-50 employees) and revenue range (1M-10M) align with mid-market institutions seeking specialized radiopharmaceutical consulting, indicating potential for repeat engagements with hospitals, research centers, and contract research organizations.

Technology stack leverage Utilization of cloud, analytics, and customer experience tools (AWS, Hotjar, Zendesk, Microsoft 365, CMS platforms) suggests opportunities to cross-sell technology-enabled services such as data workflow automation, user support optimization, and documentation portals as part of a bundled offering.